Nuventra Pharma Sciences is now Allucent. Learn more here.

Phase 1 Site Selection: Renal and Hepatic Impairment Studies

Selecting the proper site for your Phase 1 study is of critical importance to the success of your program. One question we have heard frequently from our clients is “What sites are currently active for a Phase 1 study? Where do we start the search?”

To help answer this question, we have compiled a list of sites that are actively recruiting or conducting Renal and/or Hepatic impairment studies. This list is compiled from and updated on a quarterly basis.

Please note that Nuventra does not endorse any of these sites specifically – this is simply a compilation of data. If you’d like to talk about sites we’d recommend, please Contact Us.

Hepatic Impairment Site Locations

American Institute of Research, Los Angeles, CA
Apex, Munich, Germany
CRS Clinical Research Services Kiel GmbH, Kiel, Germany
CRS Clinical Research Services Monchengladbach GmbH, Monchengladbach, Nordrhein-Westfalen, Germany
Division of Clinical Pharmacology, University of Miami, Miami, FL
Duke University School of Medicine – Duke Clinical Research Institute, Durham, NC
Investigational Centre, Prague, Czechia
Investigational Drug Services (IDS) University of Miami Hospitals and Clinics, Miami, FL
Novartis Investigative Site, Anaheim, CA
Novartis Investigative Site, Orlando, FL
Novartis Investigator Site, Houston, TX
Orange County Research Center, Tustin, CA
Orlando Clinical Research Center, Orlando, FL
Pharmaceutical Research Associates CZ,  s.r.o., Praha,  Jankovcova,  Czechia
Semmelweis Egyetem Altalanos Orvostudomanyi Kar, Budapest, Hungary
Smolensk Regional Clinical Hospital, Smolensk, Russian Federation
University of California San Francisco, San Francisco, CA

Renal Impairment Site Locations

American Institute of Research, Los Angeles, CA
Anaheim Clinical Trials, Anaheim, CA
Anhui Provincial Hospital of Chinese Medicine, Hefei, China
APEX, Munich, Germany
Arensia Phase I Unit “Carol Davila” Nephrology Hospital, Bucharest, Romania
Augusta University, Augusta, GA
Brussels Clinical Research Unit, Brussels, Belgium
California Institute of Renal Research, Chula Vista, CA
Cedars-Sinai Medical Center, Los Angeles, CA
China PLA General Hospital, Beijing, China
City of Hope Comprehensive Cancer Center, Duarte, CA
Clinical Pharmacology of Miami, Miami, FL
Colorado Blood Cancer Institute, Denver, CO
CRS Clinical-Research-Services Kiel GmbH, Kiel, Germany
CRS Clinical-Research-Services M√∂nchengladbach GmbH, Mönchengladbach, Germany
DaVita Clinical Research, Lakewood, CO
Duarte Clinical Site, Duarte, CA
Flinders Medical Centre, Adelaide, Australia
Fort Wayne Medical Oncology and Hematology, Fort Wayne, IN
GSK Investigational Site, Cambridge, United Kingdom
Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou, China
HDS – Klaudian’s Hospital, Mladá Boleslav, Czech Republic
Honor Health, Scottsdale, AZ
Hospital of the University of Pennsylvania, Philadelphia, PA
Intertek USA, San Diego, CA
Inventiv Health Clinical – Research Pharmacy Unit, Miami, FL
Lehigh Valley Hospital, Allentown, PA
Lexicon Investigational Site, Miami, FL
Massachusetts General Hospital, Boston, MA
Mayo Clinic in Rochester, Rochester, MN
Medical University of South Carolina, Pediatric Nephrology, Charleston, SC
Medical University of Vienna, Vienna, Austria
Nephrology and Hypertension Associates, Middlebury, CT
New Orleans Center for Clinical Research, Knoxville, TN
Northwestern Memorial Hospital, Chicago, IL
Northwestern University Comprehensive Transplant Center, Chicago, IL
Novartis Investigative Site, Berlin, Germany
Novo Nordisk Investigational Site, Berlin, Germany
Omega Research Consultants, LLC, Debary, FL
Orange County Research Center, Tustin, CA
Orlando Clinical Research Center, Orlando, FL
Pharmaceutical Research Associates CZ, Praha, Czech Republic
Phoenix Clinical Site, Phoenix, AZ
Please Contact the Merck KGaA Communication Center, Darmstadt, Germany
Prism Clinical Research, Saint Paul, MN
Republican Clinical Hospital, Chişinău, Moldova
St. Christopher’s Hospital for Children, Philadelphia, PA
St. Joseph Krankenhaus, Berlin, Germnay
Taipei Medical University Shuang Ho Hospital, New Taipei City, Taiwan
Technical University, Munich, Germany
Tower Cancer Research Foundation, Beverly Hills, CA
U.O. Nefrologia e Dialisi, Bergamo, Italy
UCLA Hematology Center (mastocytosis), Los Angeles, CA
Universitary Hospital Clementino Fraga Filho – UFRJ, Rio de Janeiro, Brazil
University Hospital Brno, Brno, Czech Republic
University Hospital Regensburg, Regensburg, Germany
University Hospital Saarland, Homburg, Germany
University Hospitals Case Medical Center, Cleveland, OH
University of Alabama, Birmingham, AL
University of California, San Francisco, CA
University of Coloardo Anschutz Medical Campus, Aurora, CO
University of Iowa Hospitals and Clinics, Iowa City, IA
University of Kansas Medical Center, Kansas City, KS
University of Louisville, Louisville, KY
University of Miami, Miami, FL
University of Virginia – Hospital West Kidney Center Dialysis, Charlottesville, VA
University of Washington, Seattle, WA
University of Wisconsin, Madison, WI
VA Palo Alto Health Care System, Palo Alto, CA
Westwood Dialysis Center, Westwood, KS
Winship Cancer Institute of Emory University, Atlanta, GA
ZheJiang Medicine, Shaoxing, China
Zuckerberg San Francisco General Hospital, San Francisco, CA